home / stock / vlrx / vlrx news

VLRX News and Press, Valeritas Holdings From 05/11/19

Stock Information
Company Name: Valeritas Holdings
Stock Symbol: VLRX
Market: NASDAQ
Website: valeritas.com
Menu
VLRX VLRX Quote VLRX Short VLRX News VLRX Articles VLRX Message Board
Get VLRX Alerts

News, Short Squeeze, Breakout and More Instantly...
VLRX - Valeritas Holdings, Inc. (VLRX) CEO John Timberlake on Q1 2019 Results - Earnings Call Transcript

Valeritas Holdings, Inc. (VLRX) Q1 2019 Earnings Conference Call May 9, 2019 04:30 PM ET Company Participants Greg Chodaczek - Investor Relations Erick Lucera - Chief Financial Officer John Timberlake - President and Chief Executive Officer Conference Call Participants Ste...
VLRX - Valeritas EPS in-line, beats on revenue

Valeritas (NASDAQ: VLRX ): Q1 GAAP EPS of -$0.15 in-line. More news on: Valeritas Holdings, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

VLRX - Valeritas Announces First Quarter 2019 Financial Results and Updates Full Year 2019 Revenue Guidance

BRIDGEWATER, N.J., May 09, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced fi...

VLRX - Valeritas Expects First Quarter Revenue of $6.4 million

BRIDGEWATER, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , announced today it expects to report revenue of approximately $6.4 million for the first quarter ende...
VLRX - Valeritas' V-Go® Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.5 and Total Daily Insulin Dosage by 14%

BRIDGEWATER, N.J., April 26, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , today announced results from the VERDICT study at the American Association of Clinical Endocrinolog...

VLRX - Valeritas to Report First Quarter 2019 Financial Results on May 9, 2019

BRIDGEWATER, New Jersey, April 22, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today anno...

VLRX - Valeritas' V-Go® Wearable Insulin Delivery Device Demonstrates 24% Reduction in Total Daily Insulin Dosage and Lower A1C Compared to Standard Insulin Treatment

BRIDGEWATER, N.J., April 08, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , today announced the V-GoAL randomized controlled trial of 415 patients across 52 sites. V-Go users ...
VLRX - Valeritas partners with the American Association of Diabetes Educators (AADE)

BRIDGEWATER, N.J., April 01, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , a simple, all-in-one, wearable insulin delivery option for people with diabetes, today announced it...

VLRX - Valeritas inks deal for V-Go in Israel

Valeritas Holdings (NASDAQ: VLRX ) has signed an exclusive distribution agreement with TRITECH BioMed for the commercialization of its V-Go Wearable Insulin Delivery device in Israel. More news on: Valeritas Holdings, Inc., Healthcare stocks news, Stocks on the move, Read more ....

VLRX - Valeritas Announces V-Go® Distribution Agreement in Israel

BRIDGEWATER, N.J., March 28, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced ...
Previous 10 Next 10